Clinical Trials Browser

Phase 1 × OTHER × Camurati-Engelmann Syndrome × Clear all

NCT02065362 2026-01-29

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC

Phase 1 Active not recruiting

Nasopharyngeal Carcinoma, Camurati-Engelmann Syndrome

NCT00889954 2018-09-18

HERCREEM

Phase 1 Completed

Camurati-Engelmann Syndrome